Potassium voltage-gated channel subfamily KQT member 2 — Drug Target

All drugs that target Potassium voltage-gated channel subfamily KQT member 2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Antiarrhythmic [EPC] · pyrithione zinc

Marketed (2)

• Multaq · Sanofi · Antiarrhythmic [EPC] · Cardiovascular
  Multaq works by blocking abnormal electrical signals in the heart to restore a normal heartbeat.
• Zinc Pyrithione · pyrithione zinc · Immunology
  Zinc Pyrithione works by inhibiting the activity of a specific potassium channel in the skin, which helps to reduce inflammation and prevent fungal growth.